PRINCETON, New Jersey, May 12 -- Bristol Myers Squibb, a biopharmaceutical company, issued the following news release:

* * *

Bristol Myers Squibb and Hengrui Pharma Announce Strategic Agreements to Advance Innovative Medicines Across Oncology, Hematology, and Immunology

Landmark collaboration leverages complementary capabilities to drive speed in early innovation and help advance medicines for patients worldwide

Agreements include 13 programs w . . .

Click here for more information about our products